Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide-1 (GLP-1) regulates energy homeostasis via activation of the GLP-1 receptors (GLP-1Rs) in the central nervous system. However, the mechanism by which the central GLP-1 signal controls blood glucose levels, especially in different nutrient states, remains unclear. Here, we defined a population of glucose-sensing GLP-1R neurons in the dorsomedial hypothalamic nucleus (DMH), by which endogenous GLP-1 decreases glucose levels via the cross-talk between the hypothalamus and pancreas. Specifically, we illustrated the sufficiency and necessity of DMH GLP-1R in glucose regulation. The activation of the DMH GLP-1R neurons is mediated by a cAMP-PKA–dependent inhibition of a delayed rectifier potassium current. We also dissected a descending control of DMH GLP-1R –dorsal motor nucleus of the vagus nerve (DMV)–pancreas activity that can regulate glucose levels by increasing insulin release. Thus, our results illustrate how central GLP-1 action in the DMH can induce a nutrient state–dependent reduction in blood glucose level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. Exogenous GLP-1 decreases blood glucose level in the DMH. (A) Experimental paradigm for ICV injection GLP-1R agonist Exn4 experiment in WT mice. (B) ICV Exn4 caused decrease in fasting blood glucose. *P < 0.05 and ***P < 0.001 (t test). (C) To investigate DMH GLP-1R neuron response to Exn4 injection, we injected adeno-associated virus (AAV)–DIO–mCherry in the DMH of GLP-1R-Cre mice and stained with c-Fos antibody. The representative images showed that ICV Exn4 did increase c-Fos expression in GLP-1R neurons within the DMH. (D) Quantification of c-Fos–positive cell ration (relative to total GLP-1R neurons). ***P < 0.001 (t test). (E) Experimental paradigm for Exn4 injection in DMH of WT mice. (F) Fasting blood glucose decreased after Exn4 injection, an effect that was antagonized by the cAMP-PKA blocker, cAMP-Rp. *P < 0.05, **P < 0.01, and ***P < 0.001 [analysis of variance (ANOVA)], vehicle versus Exn4; #P < 0.05 (ANOVA), Exn4 versus Exn4 + cAMP-Rp (ANOVA). Numbers of animals are indicated in each panel.](https://figures.cochat.ai/paper-figures/e4e7ef7ae0eb4252a0ac638401001932/glucose-sensing-glucagon-like-peptide-1-receptor-neurons-in-the-dorsomedial-figure-1.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The DMH plays a pivotal role in long-term metabolic regulation, including energy expenditure, thermogenesis, and circadian rhythm (27–29).”
From GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
BackgroundGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationChannelrhodopsin-2-assisted circuit mapping of long-range callosal projections
Petreanu, L., Huber, D., Sobczyk, A., & Svoboda, K. (2007) · Nature Neuroscience · doi:10.1038/nn1891 · Cited by 930 · cited 3×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundMethodPyke, C., Heller, R. S., Kirk, R. K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., & Knudsen, L. B. (2014) · Endocrinology · doi:10.1210/en.2013-1934 · Cited by 876
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger
Krashes, M. J., Shah, B. P., Madara, J. C., Olson, D. P., Strochlic, D. E., Garfield, A. S., Vong, L., Pei, H., Watabe-Uchida, M., Uchida, N., et al. (2014) · Nature · doi:10.1038/nature12956 · Cited by 603
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Cork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478
Discovery, characterization, and clinical development of the glucagon-like peptides
Drucker, D. J., Habener, J. F., & Holst, J. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci97233 · Cited by 418 · cited 1×
“One important advantage of GLP-1–based therapies for diabetes is that GLP-1–induced insulin release is dependent on circulating glucose levels, making GLP-1–based therapies less likely than other insulin secretagogues to cause hypoglycemia (3, 4).”
BackgroundNeuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect
Sisley, S., Gutierrez-Aguilar, R., Scott, M., D’Alessio, D. A., Sandoval, D. A., & Seeley, R. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72434 · Cited by 397 · cited 3×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundSelf-citationA brain-liver circuit regulates glucose homeostasis
Pocai, A., Obici, S., Schwartz, G. J., & Rossetti, L. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.11.001 · Cited by 392 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundArcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
Sandoval, D. A., Bagnol, D., Woods, S. C., D'Alessio, D. A., & Seeley, R. J. (2008) · Diabetes · doi:10.2337/db07-1824 · Cited by 320 · cited 3×
“While most studies reported a hypoglycemic effect (11, 14), others have observed a hyperglycemic effect after central GLP-1 treatment (15).”
BackgroundSelf-citationBuijs, R. M., Chun, S. J., Niijima, A., Romijn, H. J., & Nagai, K. (2001) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010319)431:4<405::aid-cne1079>3.0.co;2-d · Cited by 314
Kang, L., Routh, V. H., Kuzhikandathil, E. V., Gaspers, L. D., & Levin, B. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.549 · Cited by 311
Song, Z., Levin, B. E., McArdle, J. J., Bakhos, N., & Routh, V. H. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2673 · Cited by 303
Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas
Weir, G. C., Mojsov, S., Hendrick, G. K., & Habener, J. F. (1989) · Diabetes · doi:10.2337/diab.38.3.338 · Cited by 275
Central and peripheral GLP-1 systems independently suppress eating
Brierley, D. I., Holt, M. K., Singh, A., de Araujo, A., McDougle, M., Vergara, M., Afaghani, M. H., Lee, S. J., Scott, K., Maske, C., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00344-4 · Cited by 265 · cited 2×
“Recent studies indicated that NTSGLP-1 projecting vagal afferent neurons could be activated by peripheral oxytocin but not GLP-1 (35).”
BackgroundThe Input-Output Relationship of the Cholinergic Basal Forebrain
Gielow, M. R., & Zaborszky, L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.060 · Cited by 241
Characterization of Glucosensing Neuron Subpopulations in the Arcuate Nucleus
Fioramonti, X., Contié, S., Song, Z., Routh, V. H., Lorsignol, A., & Pénicaud, L. (2007) · Diabetes · doi:10.2337/db06-0567 · Cited by 225
Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
Vrang, N., Phifer, C. B., Corkern, M. M., & Berthoud, H.-R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00732.2002 · Cited by 204
Central Control of Brown Adipose Tissue Thermogenesis
Morrison, S. F., Madden, C. J., & Tupone, D. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00005 · Cited by 191
Liu, J., Conde, K., Zhang, P., Lilascharoen, V., Xu, Z., Lim, B. K., Seeley, R. J., Zhu, J. J., Scott, M. M., & Pang, Z. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.042 · Cited by 190 · cited 17×
“(E) Experimental paradigm for CRACM as we described before (17).”
BackgroundMethodResultInfluentialSelf-citationLeptin Regulation of the Anorexic Response to Glucagon-Like Peptide-1 Receptor Stimulation
Williams, D. L., Baskin, D. G., & Schwartz, M. W. (2006) · Diabetes · doi:10.2337/db06-0558 · Cited by 178 · cited 4×
“S4D), previous studies indicate that central GLP-1 regulation of feeding behavior is likely dependent on the nutritional status (8, 18).”
BackgroundInfluentialHypothalamic glucose sensing: making ends meet
Routh, V. H., Hao, L., Santiago, A. M., Sheng, Z., & Zhou, C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00236 · Cited by 168
Leptin Directly Depolarizes Preproglucagon Neurons in the Nucleus Tractus Solitarius
Hisadome, K., Reimann, F., Gribble, F. M., & Trapp, S. (2010) · Diabetes · doi:10.2337/db10-0128 · Cited by 153
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives
Meier, J. J., Gallwitz, B., Schmidt, W. E., & Nauck, M. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01434-6 · Cited by 147
Li, C., Navarrete, J., Liang-Guallpa, J., Lu, C., Funderburk, S. C., Chang, R. B., Liberles, S. D., Olson, D. P., & Krashes, M. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.10.016 · Cited by 145
Glucose Sensing Neurons in the Ventromedial Hypothalamus
Routh, V. H. (2010) · Sensors · doi:10.3390/s101009002 · Cited by 139
Burmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · Diabetes · doi:10.2337/db16-1102 · Cited by 136 · cited 4×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundInfluentialSelf-citationActivation of murine pre-proglucagon–producing neurons reduces food intake and body weight
Gaykema, R. P., Newmyer, B. A., Ottolini, M., Raje, V., Warthen, D. M., Lambeth, P. S., Niccum, M., Yao, T., Huang, Y., Schulman, I. G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci81335 · Cited by 123 · cited 4×
“The Gcg-Cre transgene was created by insertion of Cre-recombinase into the Gcg gene locus of BAC (bacterial artificial chromosome) RP23-242F22 at the ATG start codon as previously described (13).”
BackgroundMethodInfluentialSelf-citationGlucagon‐like peptide‐1 in the rat brain: Distribution of expression and functional implication
Gu, G., Roland, B., Tomaselli, K., Dolman, C. S., Lowe, C., & Heilig, J. S. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23282 · Cited by 119
The Mechanism of Vagal Nerve Stimulation of Glucagon and Insulin Secretion in the Dog*
AHRÉN, B., & TABORSKY, G. J. (1986) · Endocrinology · doi:10.1210/endo-118-4-1551 · Cited by 118 · cited 1×
“In addition, a close interaction between the parasympathetic and sympathetic motor nuclei may also regulate insulin release (50, 51).”
BackgroundMacDonald, P. E., Wang, X., Xia, F., El-kholy, W., Targonsky, E. D., Tsushima, R. G., & Wheeler, M. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307612200 · Cited by 117
Scrocchi, L. A., Marshall, B. A., Cook, S. M., Brubaker, P. L., & Drucker, D. J. (1998) · Diabetes · doi:10.2337/diabetes.47.4.632 · Cited by 114 · cited 1×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundLoss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity
Lee, S. J., Sanchez-Watts, G., Krieger, J.-P., Pignalosa, A., Norell, P. N., Cortella, A., Pettersen, K. G., Vrdoljak, D., Hayes, M. R., Kanoski, S. E., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.008 · Cited by 95 · cited 1×
“7A), although RPa, which mediates a sympathetic activity (41, 48), also receives some afferents from DMHGLP-1R (fig.”
BackgroundIONESCU, E., ROHNER-JEANRENAUD, F., BERTHOUD, H.-R., & JEANRENAUD, B. (1983) · Endocrinology · doi:10.1210/endo-112-3-904 · Cited by 94
Estrogen receptor-α expressing neurons in the ventrolateral VMH regulate glucose balance
He, Y., Xu, P., Wang, C., Xia, Y., Yu, M., Yang, Y., Yu, K., Cai, X., Qu, N., Saito, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15982-7 · Cited by 91 · cited 1×
“Here, we used 1 and 5 mM glucose to mimic low and high nutrient states, respectively (38, 45).”
MethodBurmeister, M. A., Ferre, T., Ayala, J. E., King, E. M., Holt, R. M., & Ayala, J. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2011 · Cited by 81 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundBrain glucosensing and the KATP channel
Levin, B. E., Dunn-Meynell, A. A., & Routh, V. H. (2001) · Nature Neuroscience · doi:10.1038/87405 · Cited by 76
Mei, Y., Vaudry, D., Basille, M., Castel, H., Fournier, A., Vaudry, H., & Gonzalez, B. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03227.x · Cited by 63
Pérez-Tilve, D., González-Matías, L., Aulinger, B. A., Alvarez-Crespo, M., Gil-Lozano, M., Alvarez, E., Andrade-Olivie, A. M., Tschöp, M. H., D'Alessio, D. A., & Mallo, F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00464.2009 · Cited by 61 · cited 2×
“While most studies reported a hypoglycemic effect (11, 14), others have observed a hyperglycemic effect after central GLP-1 treatment (15).”
BackgroundAflaki, M., Qi, X., Xiao, L., Ördög, B., Tadevosyan, A., Luo, X., Maguy, A., Shi, Y., Tardif, J., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.113.302982 · Cited by 57 · cited 14×
“Previous studies have indicated that adenosine 3′,5′-monophosphate (cAMP) may regulate IKd (23) and that GLP-1 can activate protein kinase A (PKA) signaling (24).”
BackgroundInfluentialSynaptic Inputs to the Mouse Dorsal Vagal Complex and Its Resident Preproglucagon Neurons
Holt, M. K., Pomeranz, L. E., Beier, K. T., Reimann, F., Gribble, F. M., & Rinaman, L. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2145-19.2019 · Cited by 51
Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains
Cheepsunthorn, P., Palmer, C., Menzies, S., Roberts, R. L., & Connor, J. R. (2001) · Journal of Comparative Neurology · doi:10.1002/1096-9861(20010319)431:4<382::aid-cne1077>3.0.co;2-# · Cited by 50
Glucagon and the Glucagon-like Peptides
Drucker, D. J. (1990) · Pancreas · doi:10.1097/00006676-199007000-00018 · Cited by 49
Characterization of pancreas-projecting rat dorsal motor nucleus of vagus neurons
Browning, K. N., Coleman, F. H., & Travagli, R. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00549.2004 · Cited by 46 · cited 2×
“Habener, Glucagonlike peptide I (7-37) actions on endocrine pancreas.”
BackgroundLiu, J.-J., Bello, N. T., & Pang, Z. P. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1942-17.2017 · Cited by 44 · cited 1×
“Here, we used 1 and 5 mM glucose to mimic low and high nutrient states, respectively (38, 45).”
MethodSelf-citationPang, Z. P., Deng, P., Ruan, Y., & Xu, Z. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10948.2002 · Cited by 37 · cited 1×
“Electrophysiology Electrophysiology was performed as described previously (57) with minor modifications.”
MethodSelf-citationMelanocortin 3 receptor-expressing neurons in the ventromedial hypothalamus promote glucose disposal
Sutton, A. K., Goforth, P. B., Gonzalez, I. E., Dell’Orco, J., Pei, H., Myers, M. G., & Olson, D. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103090118 · Cited by 29
Kreisler, A. D., & Rinaman, L. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00243.2015 · Cited by 27 · cited 2×
“It has been reported that gastrointestinal distension and large liquid intakes can induce c-Fos expression in this NTS population (33, 34).”
BackgroundBrowning, K. N., Coleman, F. H., & Travagli, R. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00560.2004 · Cited by 26 · cited 1×
“Neural-pancreatic research has revealed that, in addition to the pancreatic hormones and peptides, the DVC is a major brain region involved in mediating insulin secretion (46, 47).”
BackgroundFgf15 Neurons of the Dorsomedial Hypothalamus Control Glucagon Secretion and Hepatic Gluconeogenesis
Picard, A., Metref, S., Tarussio, D., Dolci, W., Berney, X. P., Croizier, S., Labouèbe, G., & Thorens, B. (2021) · Diabetes · doi:10.2337/db20-1121 · Cited by 25 · cited 2×
“7A), although RPa, which mediates a sympathetic activity (41, 48), also receives some afferents from DMHGLP-1R (fig.”
BackgroundThe Anorectic Effect of GLP-1 in Rats Is Nutrient Dependent
Sandoval, D., Barrera, J. G., Stefater, M. A., Sisley, S., Woods, S. C., D’Alessio, D. D., & Seeley, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051870 · Cited by 22
Self-citationHe, Y., Zhan, X., Yang, G., Sun, J., & Mei, Y. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159160 · Cited by 17
Kurose, T., Tsuda, K., Ishida, H., Tsuji, K., Okamoto, Y., Tsuura, Y., Kato, S., Usami, M., Imura, H., & Seino, Y. (1992) · Diabetologia · doi:10.1007/bf02221678 · Cited by 16 · cited 1×
“In addition, a close interaction between the parasympathetic and sympathetic motor nuclei may also regulate insulin release (50, 51).”
BackgroundYang, G., Zhou, M., Ren, Z., Xu, J., & Mei, Y. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000331725 · Cited by 5
Zhang, Y., Zhang, Y., Wang, Z., Sun, Y., Jiang, X., Xue, M., Yu, Y., & Tao, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111185 · Cited by 4
Cited by
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
Kim, K. S., Park, J. S., Hwang, E., Park, M. J., Shin, H. Y., Lee, Y. H., Kim, K. M., Gautron, L., Godschall, E., Portillo, B., et al. (2024) · Science · doi:10.1126/science.adj2537 · Cited by 148
Singh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., El Ouaamari, A., Wheeler, M. B., & Pang, Z. P. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00914-3 · Cited by 98
“The morphological analysis of the axonal terminals revealed dense GLP-1 neuronal terminals in the hypothalamus, especially in the PVN, DMH, ARC, and the medial vestibular parvicellular subfields nucleus (MvePC) (Fig.”
BackgroundResultSelf-citationBlood‐Glucose‐Powered Metabolic Fuel Cell for Self‐Sufficient Bioelectronics
Maity, D., Ray, P. G., Buchmann, P., Mansouri, M., & Fussenegger, M. (2023) · Advanced Materials · doi:10.1002/adma.202300890 · Cited by 71
GLP-1 programs the neurovascular landscape
Chen, B., Yu, X., HORVATH-DIANO, C., Ortuño, M. J., Tschöp, M. H., Jastreboff, A. M., & Schneeberger, M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.09.003 · Cited by 62
Liu, L., Huang, Z., Zhang, J., Wang, M., Yue, T., Wang, W., Wu, Y., Zhang, Z., Xiong, W., Wang, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52815-3 · Cited by 58
Self-citation
Metadata
- Authors
- Huang, Z., Liu, L., Zhang, J., Conde, K., Phansalkar, J., Li, Z., Yao, L., Xu, Z., Wang, W., Zhou, J., Bi, G., Wu, F., Seeley, R. J., Scott, M. M., Zhan, C., Pang, Z. P., & Liu, J.
- Affiliations
- University of Science and Technology of China (CN)
- Rutgers, The State University of New Jersey (US)
- CAS Key Laboratory of Brain Function and Diseases, Life Science School, University of Science and Technology of China, Anhui, China.
- Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.
- University of Michigan (US)
- University of Virginia (US)
- Corresponding author
- Huang, Zhaohuan
- Liu, Ling
- Zhang, Jian
- Liu, Ji
- ORCID
- Venue
- Science Advances
- Published
- 2022-06-10
- Volume
- 8
- Issue
- 23
- Pages
- eabn5345-eabn5345
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC9177072
- OpenAlex
- W4282930998
- Cited by
- 78
- References
- 57
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 15 · 2023: 14 · 2022: 4
- FWCI
- 7.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH116694)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK020572)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucagon-like peptide-1, GLP-1 receptor, dorsomedial hypothalamus, glucose detection, blood glucose regulation, energy homeostasis, dorsal motor nucleus of the vagus, insulin secretion, cAMP/PKA signaling, delayed rectifier potassium current
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Blood Glucose, Glucose, Hypothalamus, Neurons, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.